Navigation Links
SuperGen Reports 2008 Second Quarter Financial Results

stigational New Drug (IND) application with the Food and Drug Administration (FDA) of a second drug emanating from the acquired technology.

-- Additional receipts related to the sale of products to be paid by Mayne Pharma are anticipated during 2008 in a range from $1.6 million to $2.6 million. These payments will be classified as gain on sale of products.

-- Included in total operating expenses for 2008 is a reduced amount from previous guidance for non-cash stock-based compensation expense estimated at $3.5 million annually.

-- Based on the revised 2008 financial guidance loss from operations is estimated in a range from $16.6 million to $18.6 million.

-- Revised weighted average shares outstanding for 2008 are estimated at 58.1 million common shares.

Recent Corporate Events:

-- April 2008: The Company had multiple abstracts accepted for oral and

poster presentation at the American Association of Cancer Research

(AACR) Annual Meeting, that took place April 12-16 in San Diego,

California. Highlights of the presentations are included below:

-- SGI-1776, our lead pre-clinical PIM kinase inhibitor, was found to

cause tumor regression in acute myelogenous leukemia (AML) xenograft

models (Abstract No. 4974). In an oral presentation entitled, "A

potent small molecule PIM kinase inhibitor with activity in cell

lines from hematological and solid malignancies," Dr. Steven Warner,

SuperGen's Manager, Discovery Biology, detailed how scientists used

the Company's CLIMB(TM) technology to build a model that allowed for

the creation of small molecule PIM kinase inhibitors. SGI-1776 was

identified as a potent and selective inhibitor of the PIM kinases,

inducing apoptosis and cell cycle arrest, thereby causing a

reduction in phospho-BAD levels and enhancement of mTOR inhibit

SOURCE SuperGen, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Dr. Audrey F. Jakubowski of SuperGen Retires as Chief Regulatory and Quality Officer
2. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
3. SuperGen to Announce 2007 Fourth Quarter and Fiscal Year-End Financial Results March 3, 2008
4. SuperGen Reports 2007 Fourth Quarter and Annual Financial Results
5. SuperGen to Announce 2008 First Quarter Financial Results April 28, 2008
6. SuperGen to Webcast 3rd Annual Analyst Day on April 29, 2008
7. SuperGen Reports 2008 First Quarter Financial Results
8. SuperGen to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 29, 2008
9. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
10. QMed, Inc. Reports July Medicare SNP Enrollments
11. Phlo Affiliate Reports Expanded Coverage to Oregon Border
Post Your Comments:
(Date:10/7/2015)... 7, 2015 Boston Scientific (NYSE: ... the Boston Scientific Connected Patient Challenge , an ... use of remote patient monitoring to enhance patient care.  ... can submit their ideas and collaborate on solutions through ... Cambridge, MA where they ...
(Date:10/7/2015)... Oct. 7, 2015  ChromaDex Corp. (OTCQX: CDXC), ... ingredients that creates science-based solutions for dietary supplement, ... pharmaceutical products, today announced that the October 1 ... Founder, is now available for on-demand viewing at ...   --> LINK: ...
(Date:10/7/2015)...  October is National Liver Awareness Month and in ... a portion of its October profits to support the ... "TRL is ... ways; whether it is by providing the highest quality ... in different disease and investigation areas, or directly donating ...
(Date:10/7/2015)... ... October 07, 2015 , ... Park Systems , world-leader ... to provide a comprehensive overview of the innovations in smart coatings using nanoparticle ... . This webinar will be given by Professor Roberto Advincula, professor with the ...
Breaking Biology Technology:
... a 360-degree look at the "state of play" on ... CQ Forum will include a panel discussion with industry ... complex structures of biologics products vs. traditional pharmaceuticals. Are ... save money for consumers? What is the right length ...
... - AEterna Zentaris Inc. (NASDAQ: AEZS ; ... therapy and oncology, today reported that patient follow-up in ... 3 program in benign prostatic hyperplasia (BPH) with its ... completed at the end of this week. Therefore, data ...
... ... of the Year presented by Frost & Sullivan , ... Charlottesville, VA, New York, NY and Paris, France (PRWEB) June 15, ... tools, announces that it has received the prestigious 2009 Global Pharmaceutical CRM Growth Strategy Leadership ...
Cached Biology Technology:
(Date:9/28/2015)... , September 28, 2015 ... Component (Hardware & Software), Product (Scanner & Others), Application ... & Defense, & Others) & Geography Global - Forecast ... expected to reach USD 3627.90 Million by 2020, at ... Browse 65 market data T ables ...
(Date:9/26/2015)... , Sept. 26th, 2015  Results of ... will be unveiled today at the Stanford Medicine ... Engagement Using iPad Dashboards, Connected Health Devices and ... of Pharmacy 3.0, will explain how senior patients ... data to their pharmacist via the TactioRPM remote ...
(Date:9/24/2015)... , September 24, 2015 ... september 2015 Kerv ( ... finanstjänster, lanserar idag världens första kontaktlösa betalningsring ... in 77 000 GBP för massproduktion via ... ) , Kerv-bärare kan ...
Breaking Biology News(10 mins):
... who diet and develop disordered eating behaviors (unhealthy and ... unhealthy practices into young adulthood and beyond, according to ... published in the July 2011 issue of the ... findings from the current study argue for early and ...
... in reconstructive and cosmetic surgery and in the food industry. ... within the protein need to be hydroxylated. BioMed Central,s open ... first time the α1 chain of type 1 collagen has ... to human collagen. Most collagen used is derived from ...
... researchers identified the top pathogens, pests and weeds affecting ... Soybean aphid, soybean rust, soybean cyst nematode, Sclerotina ... blotch, were featured as some of the top biotic ... the future. "Enormous potential exists to increase future ...
Cached Biology News:
... a silica based spin filter membrane to isolate ... DNA band is cut from an agarose gel ... The gel slice is melted irreversibly in a ... bound to the silica spin filter membrane and ...
... incorporation of Br-dUTP results in a stronger ... a fluorescein-labeled anti-BrdU antibody. Propidium iodide/RNase ... to counterstain the total DNA. Features and ... improved detection than found by using biotin- ...
Mouse polyclonal antibody raised against a partial recombinant WRB. NCBI Entrez Gene ID = 7485...
Biology Products: